# STIMUFEND

NDC: 72603-402
Generic name: pegflilgrastim-fpgk
Labeler / Manufacturer: NORTHSTAR RX LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251229

FDA application: BLA761173

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-402"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-402
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e36ee55-7f13-41db-9d49-2f7a92f3b750